Matthew Chun

Company: Amgen Inc.

Job title: Senior Principal Scientist

Seminars:

Advancing T-cell Engagers for Solid Tumors 11:30 am

T cell engager molecules have demonstrated clinical benefit in hematological malignancies and there is growing evidence of activity in solid tumors This presentation will highlight key findings from recent trials along with observations from nonclinical studies that inform on T cell engager molecule mechanism of action and new engineering approaches to address clinically-observed challengesRead more

day: Day One